ArticleJournal of neuroinflammation2026
Altered phenotype and gene expression of regulatory T cells (Tregs) in children with Autism, and the relationship with comorbid gastrointestinal symptoms.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immunometabolic Stratification of Autism Spectrum Disorder by CD4Metabolites · 2026Article
- Neuroinflammatory mechanisms and pharmacological advances in autism spectrum disorder: from inflammatory pathways to targeted interventions.Frontiers in immunology · 2026Review
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by social deficits and stereotypic behaviors. In ASD, increased numbers of inflammatory cells and their mediators have been found in peripheral blood, brain, and gastrointestinal (GI) tissues. Regulatory T cells (Tregs) play a crucial role in suppressing inflammatory processes that, if disrupted, can result in inflammation and development of a variety of immunological conditions. In this study, we sought to characterize Tregs populations using flow cytometric and gene transcriptomic approaches in children with ASD (n = 36) and typically developing (TD) children (n = 18) enrolled in the Childhood Autism Risk from Genetics and Environment (CHARGE)-back study. We also examined differences in the frequencies of activated Tregs in ASD groups when stratified by stable co-occurring GI status. The frequency of gut homing α4β7+Tregs positive for inhibitory receptors GITR, LAP, and/or GARP were altered based on the presence of GI symptoms. Analysis of mRNA isolated from CD4+CD25+Tregs, showed 213 differentially expressed genes (DEGs) between the ASD and TD children. Upregulated DEGs were enriched in Gene Ontology (GO) Biological Processes involved in epigenetic regulation including ‘chromatin organization’, whereas Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were involved in metabolism, including ‘lipid and atherosclerosis’ and ‘pantothenate and CoA biosynthesis’. Upregulation of immune signaling genes (MAPK3, JAK2, and CASP3) was also noted in ASD Tregs. Downregulated DEGs consisted of genes enriched in immune terms including the GO term ‘leukocyte differentiation’ and KEGG pathways ‘Parkinson disease’ and ‘protein processing in endoplasmic reticulum’. Behavioral correlation analysis pointed to a potential relationship between inappropriate speech scores and lower frequencies of Tregs. Overall, these data support the hypothesis of altered Tregs cell biology in ASD that ultimately may drive a lack of control of inflammatory immune responses in ASD shifting from a balanced state to a dysregulated/inflammatory state.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.